The Immunolocalization of Mast Cells in the Pathology of Oral Submucous Fibrosis

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Jul 10

PMID 37425595

Authors

Seema Gupta

Manish Sharma

Satyabrat Banerjee

Kiran Holikatti

Priyanka Kamble

Jay V Goyal

Affiliations

Soon will be listed here.

Abstract

Background Oral submucous fibrosis (OSMF) is a prevalent precancerous condition of the oral cavity and an ambiguity to clinicians because of its indistinguishable etiopathogenesis. Previous studies could not establish a definite role of mast cells (MCs) in the fibrosis of stroma. The present study was done to study the histopathological changes in OSMF and to determine the association of mast cells (MCs) and their degranulated components with vascularity. Methods A retrospective case-control study involved 40 cases of various histopathological grades of OSMF and was compared with 10 cases of normal buccal mucosa by using a cluster of differentiation 117(CD117) kit for the identification of MCs and Masson's trichrome stain to study the number of blood vessels (BVs). Results The present study indicated that advanced cases of OSMF had keratinized epithelium with atrophic changes and moderate to advanced fibrosis of stroma with the involvement of underlying muscles. The MC density and the number of blood vessels were progressively reduced in OSMF as the grade advanced compared to healthy controls. Conclusion An increase in the mast cell density in the initial stages of OSMF suggests their definite role in the initiation of fibrosis and secondary changes to the epithelium such as atrophy.

Citing Articles

Exploring the role of angiogenesis in fibrosis and malignant transformation in oral submucous fibrosis: a systematic review and meta-analysis.

R K, Chandra A, Raja D, Khairnar M, Agrawal R J Korean Assoc Oral Maxillofac Surg. 2024; 50(5):243-252.

PMID: 39482099 PMC: 11535123. DOI: 10.5125/jkaoms.2024.50.5.243.

Role of mast cells in the pathogenesis of oral submucous fibrosis: a systematic review and meta-analysis.

Bijai L, Aboalela A, Albalawi F, Khanagar S, Iyer K BMC Oral Health. 2024; 24(1):1219.

PMID: 39402549 PMC: 11476548. DOI: 10.1186/s12903-024-05025-8.

Comparative assessment of the efficacy of an intralesional injection of placentrex, hyaluronidase and dexamethasone in the management of oral submucous fibrosis: A randomized controlled trial.

Goyal J, Iyer S, Palande C, Brahmankar U, John J, Patil K Med Int (Lond). 2024; 4(2):19.

PMID: 38476987 PMC: 10928652. DOI: 10.3892/mi.2024.143.

References

Azizi Mazreah S, Shahsavari M, Kalati P, Azizi Mazreah H . Immunohistochemical evaluation of CD117 in mast cell of aggressive periodontitis. J Indian Soc Periodontol. 2020; 24(3):216-220. PMC: 7307478. DOI: 10.4103/jisp.jisp_243_19. View

Rathore A, Gupta A, Shetty D, Kumar K, Dhanapal R . Redefining epithelial characterization in oral submucous fibrosis using morphometric analysis. J Oral Maxillofac Pathol. 2017; 21(1):36-40. PMC: 5406815. DOI: 10.4103/0973-029X.203792. View

Miettinen M, Lasota J . KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005; 13(3):205-20. DOI: 10.1097/01.pai.0000173054.83414.22. View

Rajendran R, Paul S, Mathews P, Raghul J, Mohanty M . Characterisation and quantification of mucosal vasculature in oral submucous fibrosis. Indian J Dent Res. 2006; 16(3):83-91. View

Cirillo N, Duong P, Er W, Do C, De Silva M, Dong Y . Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis. Biomolecules. 2022; 12(5). PMC: 9138976. DOI: 10.3390/biom12050664. View

Shrestha A, Keshwar S, Raut T . Evaluation of Mast Cells in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma. Int J Dent. 2021; 2021:5609563. PMC: 8418547. DOI: 10.1155/2021/5609563. View

Prabhu R, Prabhu V, Chatra L, Shenai P, Suvarna N, Dandekeri S . Areca nut and its role in oral submucous fibrosis. J Clin Exp Dent. 2015; 6(5):e569-75. PMC: 4312688. DOI: 10.4317/jced.51318. View

Ribatti D . The Staining of Mast Cells: A Historical Overview. Int Arch Allergy Immunol. 2018; 176(1):55-60. DOI: 10.1159/000487538. View

PINDBORG J, Singh B . FORMATION OF VESICLES IN ORAL SUBMUCOUS FIBROSIS. Acta Pathol Microbiol Scand. 1964; 62:562-6. DOI: 10.1111/apm.1964.62.4.562. View

10.

Tamgadge S, Tamgadge A . Histopathology of Oral Submucous Fibrosis in Third Dimension with an Additional note on Hypothesis of Epithelial Atrophy. J Microsc Ultrastruct. 2020; 8(1):31-34. PMC: 7045625. DOI: 10.4103/JMAU.JMAU_23_19. View

11.

Hernandez-Morera P, Castano-Gonzalez I, Travieso-Gonzalez C, Mompeo-Corredera B, Ortega-Santana F . Quantification and Statistical Analysis Methods for Vessel Wall Components from Stained Images with Masson's Trichrome. PLoS One. 2016; 11(1):e0146954. PMC: 4711946. DOI: 10.1371/journal.pone.0146954. View

12.

Pandiar D, Shameena P . Immunohistochemical expression of CD34 and basic fibroblast growth factor (bFGF) in oral submucous fibrosis. J Oral Maxillofac Pathol. 2014; 18(2):155-61. PMC: 4196280. DOI: 10.4103/0973-029X.140718. View

13.

Kumar L, Mathew P, Madhavan N, Siddique S, Kshetrimayum N, Iyer K . Evaluation of mast cells and burning sensation in various stages of Oral Submucous Fibrosis. J Oral Biol Craniofac Res. 2020; 10(4):430-434. PMC: 7414006. DOI: 10.1016/j.jobcr.2020.07.005. View

14.

Fukuda T, Kamishima T, Tsuura Y, Suzuki T, Kakihara T, Naito M . Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophil/mast cell precursors from chronic myelogenous leukaemia. J Pathol. 1995; 177(2):139-46. DOI: 10.1002/path.1711770207. View

15.

SIRSAT S, PINDBORG J . Mast cell response in early and advanced oral submucous fibrosis. Acta Pathol Microbiol Scand. 1967; 70(2):174-8. DOI: 10.1111/j.1699-0463.1967.tb01279.x. View

16.

Desai R, Mamatha G, Khatri M, Shetty S . Immunohistochemical expression of CD34 for characterization and quantification of mucosal vasculature and its probable role in malignant transformation of atrophic epithelium in oral submucous fibrosis. Oral Oncol. 2010; 46(7):553-8. DOI: 10.1016/j.oraloncology.2010.04.004. View

17.

Pujari R, Vidya N . Mast cell density in oral submucous fibrosis: a possible role in pathogenesis. Int J Health Sci (Qassim). 2013; 7(1):23-9. PMC: 3612412. DOI: 10.12816/0006017. View

18.

Tekade S, Chaudhary M, Tekade S, Sarode S, Wanjari S, Gadbail A . Early Stage Oral Submucous Fibrosis is Characterized by Increased Vascularity as Opposed to Advanced Stages. J Clin Diagn Res. 2017; 11(5):ZC92-ZC96. PMC: 5483819. DOI: 10.7860/JCDR/2017/25800.9948. View

19.

Bradding P, Pejler G . The controversial role of mast cells in fibrosis. Immunol Rev. 2018; 282(1):198-231. DOI: 10.1111/imr.12626. View